This bill directs the Department of Energy to establish at least two "bioindustrial technology maturation facilities" by September 2030 to help biotechnology companies scale up their products from research stage to commercial production. The facilities will serve as shared resources available to government agencies, private companies, and academic institutions, offering services like pilot testing, equipment access, workforce training, and digital data-sharing platforms to advance biotechnology-based manufacturing. The bill affects biotechnology innovators, manufacturers, energy companies, and rural communities by addressing what Congress identifies as a major barrier to American biotech competitiveness—the lack of available, affordable infrastructure to test and demonstrate new biomanufacturing processes at scale. The legislation authorizes $225.5 million in funding over fiscal years 2026 through 2030, and requires the Department of Energy to develop a strategic implementation plan within six months and submit annual progress reports to Congress.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.